000			02365 a2200637 4500
005			20250515220023.0
264		0	_c20101025
008			201010s 0 0 eng d
022			_a1573-7217
024	7		_a10.1007/s10549-010-0866-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aGuarneri, Valentina
245	0	0	_aBevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. _h[electronic resource]
260			_bBreast cancer research and treatment _cJul 2010
300			_a181-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aBreast Neoplasms _xcomplications
650	0	4	_aDiphosphonates _xadverse effects
650	0	4	_aDocetaxel
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Synergism
650	0	4	_aFemale
650	0	4	_aGenes, erbB-2
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aJaw Diseases _xchemically induced
650	0	4	_aMiddle Aged
650	0	4	_aMulticenter Studies as Topic _xstatistics & numerical data
650	0	4	_aNeoplasm Metastasis
650	0	4	_aOral Hygiene
650	0	4	_aOsteonecrosis _xchemically induced
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aProspective Studies
650	0	4	_aRandomized Controlled Trials as Topic _xstatistics & numerical data
650	0	4	_aTaxoids _xadministration & dosage
650	0	4	_aVinblastine _xadministration & dosage
650	0	4	_aVinorelbine
700	1		_aMiles, David
700	1		_aRobert, Nicholas
700	1		_aDiéras, Véronique
700	1		_aGlaspy, John
700	1		_aSmith, Ian
700	1		_aThomssen, Christoph
700	1		_aBiganzoli, Laura
700	1		_aTaran, Tanya
700	1		_aConte, PierFranco
773	0		_tBreast cancer research and treatment _gvol. 122 _gno. 1 _gp. 181-8
856	4	0	_uhttps://doi.org/10.1007/s10549-010-0866-3 _zAvailable from publisher's website
999			_c19721603 _d19721603